The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 3 trial of momelotinib (MMB) vs ruxolitinib (RUX) in JAK inhibitor (JAKi) naive patients with myelofibrosis (MF).
 
Ruben A. Mesa
Honoraria - AOP Orphan Pharmaceuticals; Novartis; shire
Consulting or Advisory Role - Baxalta; Galena Biopharma; Incyte; Novartis
Research Funding - Celgene (Inst); CTI (Inst); Genentech (Inst); Gilead Sciences (Inst); Incyte (Inst); NS Pharma (Inst); Pfizer (Inst); Pharmaessentia (Inst); Promedior (Inst)
Travel, Accommodations, Expenses - AOP Orphan Pharmaceuticals; Incyte; Novartis
 
Jean-Jacques Kiladjian
Honoraria - Novartis; Shire
Consulting or Advisory Role - AOP Orphan Pharmaceuticals; Novartis
Research Funding - AOP Orphan Pharmaceuticals (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
John V. Catalano
Consulting or Advisory Role - Celgene; Gilead Sciences; Roche
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene
 
Timothy Devos
Consulting or Advisory Role - Gilead Sciences; Janssen; Novartis; Shire
Speakers' Bureau - Incyte; Janssen; Novartis
 
Miklos Egyed
No Relationships to Disclose
 
Andrzei Hellman
Travel, Accommodations, Expenses - ARIAD; Bristol-Myers Squibb; Novartis
 
Donal McLornan
Honoraria - Jazz Pharmaceuticals
Speakers' Bureau - Novartis
 
Kazuya Shimoda
No Relationships to Disclose
 
Elliott F. Winton
Consulting or Advisory Role - Gilead Sciences; Incyte
Research Funding - Gilead Sciences (Inst); Incyte (Inst)
 
Wei Deng
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
 
Ronald L. Dubowy
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
 
Julia D. Maltzman
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
 
Francisco Cervantes
Consulting or Advisory Role - ARIAD; Gilead Sciences; Novartis; Pfizer
Speakers' Bureau - ARIAD; Gilead Sciences; Novartis; Pfizer
 
Jason R. Gotlib
Research Funding - Gilead Sciences